Probiotics Market is Estimated To Attain $220.14 Billion by 2030

 Probiotics Market Growth & Trends

The global probiotics market size is expected to reach USD 220.14 billion by 2030, growing at a CAGR of 14.0% from 2023 to 2030, according to a new study by Grand View Research, Inc. The market is experiencing steady growth driven by several factors including shifting dietary preferences toward healthier foods coupled with the rising consumer awareness about digestive health products. Manufacturers in the industry are increasingly focused on distribution agreements and partnerships for probiotic sales. For instance, in September 2020, OptiBiotix Health Plc., a UK-based probiotic nutritional supplement manufacturer, announced an exclusive distribution agreement with Ayalla Marketing for the former’s product distribution in Brazil. In such an agreement, manufacturers often decide the minimum order quantity to facilitate cost-effective shipments.

In addition, Meluka Australia, a company that expanded its probiotic range in collaboration with Probiotics Australia in 2021, also expanded its retail channels through other strategic alliances. The company launched an e-commerce channel via WhatsApp in March 2022. It implemented a conversational messaging technology offered by Gupshup for customer engagement. Its e-commerce store is accessible to Australian customers via the WhatsApp platform. Moreover, e-commerce is increasingly becoming popular owing to the availability of a wide range of supplements and probiotic food products. Various companies, especially new entrants, in the global market are collaborating with e-commerce companies to promote their products as well as achieve maximum market penetration.

In addition, supplement manufacturers are increasingly incorporating functional ingredients into products to increase their nutritional value. Ingredient suppliers and supplement manufacturers are focusing on product innovation to expand their portfolio of probiotics and probiotic-based foods and better cater to the specific nutrition conditions of consumers with digestive health problems. For example, in August 2021, SkinBio Therapeutics launched new probiotic supplements targeted at the skin condition psoriasis. This product launch was aimed at expanding the use of probiotics in different application areas.

Request a free sample copy or view report summary: Probiotics Market Report

Probiotics Market Report Highlights

• The demand for probiotic dietary supplements is expected to grow at a CAGR of 14.1% from 2023 to 2030, driven by the growing consumer awareness of the health benefits offered by probiotic supplements
• The demand for yeast-based probiotics is projected to grow at a CAGR of 13.4% during the forecast period. Dietary supplements are made using yeast as it has proteins, amino acids, vitamin B, and peptides, and is safe for all age groups
• The sales of probiotics through supermarkets/hypermarkets dominated the market in 2022 with a revenue share of over 30% and are expected to continue dominance throughout the forecast period. The availability of a wide range of product offerings, also enabling easy comparisons for customers, is expected to drive this dominance
• The demand for probiotics in the Middle East & Africa region is expected to grow at a CAGR of nearly 15% during the forecast period. It is mainly driven by the increasing demand in countries, such as Saudi Arabia, South Africa, and UAE

Access Press Release@ https://www.grandviewresearch.com/press-release/global-probiotics-market

Probiotics Market Segmentation

Grand View Research has segmented the global probiotics market based on product, ingredient, end-use, distribution channel, and region:

Probiotics Product Outlook (Revenue, USD Million, 2017 - 2030)

• Probiotic Food & Beverages
  • Dairy Products
  • Non-dairy
  • Cereals
  • Baked Food
  • Fermented Meat
  • Dry Foods
• Probiotic Dietary Supplements
  • Food Supplements
  • Nutritional Supplements
  • Specialty Supplements
  • Infant Formula
• Animal Feed

Probiotics Ingredient Outlook (Revenue, USD Million, 2017 - 2030)

• Bacteria
• Yeast

Probiotics End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Human Probiotics
• Animal Probiotics

Probiotics Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Hypermarkets/Supermarkets
• Pharmacies/Drugstores
• Specialty Stores
• Online Stores
• Others

Probiotic Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players in Probiotics Market

• Arla Foods Group
• BioGaia AB
• Hansen Holding A/S
• Danone
• DuPont De Nemours, Inc.
• General Mills, Inc.
• i-Health, Inc.
• Lallemand Inc.
• Lifeway Foods Inc
• Mother Dairy Fruit & Vegetable Pvt. Ltd
• Kerry
• Nestle S.A.
• Probi AB
• Yakult Honsha Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Protein Ingredients Market to Observe Strong Development by 2030: Grand View Research Inc.

 Protein Ingredients Market Growth & Trends

The global protein ingredients market size is expected to reach USD 85.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.5% from 2021 to 2028. The market is expected to witness significant growth over the forecast period owing to increasing consumer awareness regarding maintaining a healthy diet and leading an active lifestyle. In addition, the growing popularity of adopting a high protein diet as a part of weight reduction is expected to propel the demand for protein ingredients.

Increasing innovations by various manufacturers in terms of manufacturing proteins that contain a wide range of amino acids and specific functions, including energy balance, weight loss, muscle repair, and satiety, are expected to create immense growth potential for the market over the forecast period. Moreover, ascending demand for protein ingredients among women owing to the prevalence of the ‘strong not skinny’ trend as well as the rising popularity of resistance training among women are factors likely to fuel the market growth.

There has been an increase in the demand for supplements and natural prevention, a rise in the consumption of snack-based meal replacements, and growth in the consumer demand for greater ingredient traceability and authenticity. Moreover, rising demand for higher protein density in mainstream diet and growing multiple nutritional segments addressing various consumer needs on the basis of different life stages, gender, health issues, performance demands, regional diets, and regulatory framework are some of the other major trends being observed in the market.

The protein ingredients companies have been launching new products to cater to the rising demand among health-conscious consumers. For instance, in October 2018, the company DuPont launched a new protein ingredient (pea protein) under the brand TRUPRO 2000 for use in beverage applications. DuPont introduced the new product to further expand its product offerings and increase its penetration in the beverages industry.

Furthermore, in August 2019, Cargill, Incorporated invested in a U.S.-based company called Puris that is operating in the field of plant-based ingredients. A total sum of USD 75 million was invested to cater to the rising demand for pea protein ingredients in the U.S. market. Many international players are looking to make such investments to capitalize on the growing demand for pea protein. Urbanization, westernization of diets, population growth, expanding middle-class with higher disposable income, increasing frequency of exercise, and rising focus on leading an active and healthy lifestyle in the emerging economies, including China and India, are factors expected to drive the demand for protein ingredients.

Request a free sample copy or view report summary: Protein Ingredients Market Report

Protein Ingredients Market Report Highlights

• By product, plant proteins are expected to witness the fastest growth over the forecast period owing to the increased use of protein ingredients in food and beverages. Increasing use of plant proteins in a wide range of applications, including manufacturing of fertilizers, paper coatings, and printing inks, is creating lucrative growth opportunities for the segment
• Animal/dairy proteins held the largest revenue share of over 70.0% in 2020 owing to the growing adoption of these products in developed markets. Whey protein is expected to witness significant growth over the forecast period as it is largely popular among fitness-savvy consumers
• North America dominated the market with more than 40.0% share of the global revenue in 2020 owing to the high demand from the U.S. food and beverages sector. Consumer markets developing in Asia Pacific are growing at a high pace due to a rise in disposable income and changing lifestyle, resulting in significant growth of the regional market
• The Middle East and Africa is expected to exhibit a revenue-based CAGR of 9.6% from 2021 to 2028. This is attributed to supportive government policies as well as improved economic indicators, which have resulted in the increased availability of packaged foods amongst the urban and rural population

Access Press Release@ https://www.grandviewresearch.com/press-release/global-protein-ingredients-market-analysis

Protein Ingredients Market Segmentation

Grand View Research has segmented the global protein ingredients market on the basis of product, application, and region:

Protein Ingredients Product Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Plant Proteins
  • Cereal-based
  • Legumes-based
  • Root-based
  • Nuts & Seeds-based
  • Ancient Grains
• Animal/Dairy Proteins
  • Egg Protein
  • Milk Protein Concentrates/Isolates
  • Whey Protein Concentrates
  • Whey Protein Hydrolysates
  • Whey Protein Isolates
  • Gelatin
  • Casein/Caseinates
  • Collagen Peptides
• Microbe-based Proteins
  • Algae
  • Bacteria
  • Yeast
  • Fungi
• Insect Protein
  • Coleoptera
  • Lepidoptera
  • Hymenoptera
  • Orthoptera
  • Hemiptera
  • Diptera
  • Others

Protein Ingredients Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Food & Beverages
  • Bakery & Confectionery
  • Beverages
  • Breakfast Cereals
  • Dairy Alternatives
  • Dietary Supplements/Weight Management
  • Meat Alternatives & Extenders
  • Snacks
  • Sports Nutrition
  • Others
• Infant Formulations
• Clinical Nutrition
• Animal Feed
• Others

Protein Ingredients Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
• Central & South America
• Middle East & Africa (MEA)

List of Key Players of Protein Ingredients Market

• DuPont
• Rousselot
• Archer Daniels Midland Company
• Burcon NutraScience
• Tessenderlo Group
• Kewpie Corporation
• Roquette Frères
• The Scoular Company
• CHS Inc.
• Mead Johnson & Company, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Cell Culture Market Significant Profits Estimated to be Generated by 2030: Grand View Research Inc.

 3D Cell Culture Market Growth & Trends

The global 3D cell culture market size is expected to reach USD 3.31 billion by 2030, expanding at 11.04% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in August 2021, Amerigo Scientific launched its 3D cell culture products for research purposes with wide applications in medicine, drug discovery, and tissue engineering.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2020, CELLINK and Lonza collaborated to offer 3D bioprinting solutions to optimize access to 3-dimensional cell cultures workflows.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds.

Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

Request a free sample copy or view report summary: 3D Cell Culture Market Report

3D Cell Culture Market Report Highlights

• The scaffold-based technology segment dominated the market in 2022 with a revenue share of 48.85% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications
• Stem cell research & tissue engineering held the largest share of 33.76% in 2022, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research
• In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share of 46.34%. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
• North America region dominated the global market in 2022 with a revenue share of 45.58%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-cell-culture-market

3D Cell Culture Market Segmentation

Grand View Research has segmented the global 3D cell culture market based on technology, application, end-use, and region:

3D Cell Culture Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Scaffold Based
  • Hydrogels
  • Polymeric Scaffolds
  • Micropatterned Surface Microplates
  • Nanofiber Based Scaffolds
• Scaffold Free
  • Hanging Drop Microplates
  • Spheroid Microplates with ULA Coating
  • Magnetic Levitation
• Bioreactors    
• Microfluidics
• Bioprinting    

3D Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cancer Research
• Stem Cell Research & Tissue Engineering
• Drug Development & Toxicity Testing
• Others

3D Cell Culture End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology And Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals
• Others

3D Cell Culture Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the 3D Cell Culture Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• PromoCell GmbH
• Lonza
• Corning Incorporated
• Avantor, Inc. 
• Tecan Trading AG
• REPROCELL Inc.
• CN Bio Innovations Ltd
• Lena Biosciences

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ophthalmic Drugs Market Size Projected to Rise Lucratively during 2024 to 2030: Grand View Research Inc.

 Ophthalmic Drugs Market Growth & Trends

The global ophthalmic drugs market size is expected to reach USD 65.55 billion by 2030, garnering a CAGR of 7.80% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising awareness about ophthalmic disorders and the surge in demand for ophthalmic drugs are the factors propelling the market growth. Moreover, an increase in the prevalence of eye diseases such as age-related macular degeneration, cataract, dry eye, diabetic retinopathy, glaucoma, and others are anticipated to boost the demand for ophthalmic drugs.

According to BrightFocus Foundation in 2021, it is estimated that over 3 million Americans are living with glaucoma, and, among them over 2.7 million patients were affected by the most common type of glaucoma i.e. open-angle glaucoma. Moreover, 3.3 million people are affected by blindness and low vision in the U.S. Some of the major risk factors for glaucoma and blindness are, higher age, family history, thin cornea, and high eye pressure. This creates a wide population base for ophthalmic drugs, thereby, ensuring lucrative growth.

Furthermore, ocular therapeutic and drug delivery companies are receiving funding to expedite R&D for advancements in technologies to develop novel drugs, which is likely to fuel market growth. For instance, in June 2020, Re-Vana Therapeutics received USD 3.25 million in pre-series A funding from Qubis, ExSight Ventures, LLC, Clarendon Fund Managers, Visionary Ventures, and Techstart Ventures LLP. The funding is expected to boost the development of Re-Vana Therapeutics’ EyeLief & OcuLief biodegradable technologies that can be used for a small molecule as well as biologics delivery.

Moreover, the rising geriatric population is the key driver for the ophthalmic drugs market growth. According to Safe Eyes America, the most common risk factors for ophthalmic diseases are high age, family history, diabetes, and high blood pressure. For instance, as per AMERICA’s HEALTH RANKINGS senior report 2021 it was estimated that more than 54 million adults of age more than 65 live in the U.S., and that population accounted for 16.5% of the total population. According to Macular Degeneration Research AMD is the leading reason for blindness in U.S. people over the age of 60.

Ongoing regulatory approvals for ophthalmic products are likely to support market growth. For instance, in June 2022 Santen Pharmaceutical Co., Ltd announced that it has got marketing and manufacturing approval for the dry eye disease treatment DIQUAS LX ophthalmic solution in Japan. This solution is the improved formulation that has reduced dosing frequency and improved patient compliance.

Request a free sample copy or view report summary: Ophthalmic Drugs Market Report

Ophthalmic Drugs Market Report Highlights

• Anti-VEGF agents segment held the largest share in 2022 owing to their rising demand and lesser adverse effects
• Retinal disorders held the largest market share in 2022 owing to the rising prevalence of age-related macular degeneration and diabetic retinopathy
• The topical route of administration dominated the market in 2022 owing to factors such as the benefits of the topical route as it delivers the drug to the targeted site and ease of use
• The eye drops segment is expected to hold the largest share in 2022 owing to rising demand for eye drops, high patient compliance, and availability of OTC products
• Asia Pacific is expected to exhibit the fastest growth over the forecast period due to advancements in healthcare infrastructure, increasing demand for eye products, and a large patient pool

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ophthalmic-therapeutics-drug-market

Ophthalmic Drugs Market Segmentation

Grand View Research has segmented the global ophthalmic drugs market report based on drug class, disease, route of administration, dosage type, product type, product, and region:

Ophthalmic Drugs Drug Class Outlook (Revenue, USD Billion, 2018 - 2030)

• Anti-allergy
  • Anti-inflammatory
  • Non-steroidal drugs
• Steroidal drugs
• Anti-VEGF Agents
• Anti-glaucoma
• Others

Ophthalmic Drugs Disease Outlook (Revenue, USD Billion, 2018 - 2030)

• Dry Eye
  • Gels
  • Eye Solutions & Suspensions
  • Capsules & Tablets
  • Eye Drops
  • Ointments
• Allergies
  • Gels
  • Eye Solutions & Suspensions
  • Capsules & Tablets
  • Eye Drops
  • Ointments
• Glaucoma
  • Gels
  • Eye Solutions & Suspensions
  • Capsules & Tablets
  • Eye Drops
  • Ointments
• Eye Infection
  • Gels
  • Eye Solutions & Suspensions
  • Capsules & Tablets
  • Eye Drops
  • Ointments
• Infection
  • Gels
  • Eye Solutions & Suspensions
  • Capsules & Tablets
  • Eye Drops
  • Ointments
• Retinal Disorders
  • Retinal Disorder Treatment Market, By Type,
    • Macular Degeneration
    • Diabetic Retinopathy
  • Retinal Disorder Treatment Market, By Dosage Type,
    • Gels
    • Eye Solutions & Suspensions
    • Capsules & Tablets
    • Eye Drops
    • Ointments
  • Uveitis
    • Gels
    • Eye Solutions & Suspensions
    • Capsules & Tablets
    • Eye Drops
    • Ointments
  • Others

Ophthalmic Drugs Dosage Form Outlook (Revenue, USD Billion, 2018 - 2030)

• Gels
• Eye Solutions & Suspensions
• Capsules and Tablets
• Eye Drops
• Ointments

Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)

• Topical
  • Retinal Disorders
  • Subconjunctival
  • Intravitreal
  • Retrobulbar
  • Intracameral
• Local Ocular
• Systemic

Ophthalmic Drugs Product Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Prescription Drugs
• OTC

Ophthalmic Drugs Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Branded Drugs
• Generic Drugs

Ophthalmic Drugs Regional Outlook (Revenue, USD Billion, 2018- 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Ophthalmic Drugs Market

• Pfizer Inc.
• Alcon
• Novartis AG
• Bausch Health Companies Inc.
• Merck & Co., Inc
• Regeneron Pharmaceuticals Inc
• Allergan (AbbVie Inc)
• Bayer AG
• Genentech, Inc. (F. Hoffmann-La Roche Ltd)
• Nicox
• Coherus Biosciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Science Fiction or Reality? The Role of Gene Therapy in Regenerative Medicine

 The increasing awareness regarding advanced medical therapies supports the global regenerative medicine market demand. In addition, a strong investigational pipeline of promising candidates and expected approvals in the coming years are projected to favor market expansion. Furthermore, advancements in nanotechnology and the increasing prevalence of degenerative disorders have emphasized research to introduce novel regenerative therapies.

According to a study by Grand View Research, in 2023, the global market size of regenerative medicine was valued at USD 30.4 billion and is anticipated to expand at a CAGR of 16.8% from 2024 to 2030. Regenerative medicines have the exceptional ability to modify the elemental mechanisms of diseases. Regenerative therapies in trials deliver favorable resolutions for certain chronic indications. These solutions involve the use of multiple approaches and products, such as gene therapy, tissue-engineered products, small molecules, biologics, allogeneic & autologous stem cells, and combinational products. Supportive initiatives from governments, biotechnology & pharmaceutical companies, and healthcare providers are projected to boost the industry growth.

Where Technology meets Medicine

Novel technologies such as tissue engineering, gene therapy, and cell-based therapies are employed in regenerative medicine to offer augmented patient care with regeneration or replacement of genes, cells, organs, & tissues in patients. The increasing applications of regenerative medicine have encouraged researchers and professionals to explore the potential of novel technologies in regenerative medicine therapeutic models. For instance, developments in the fabrication of tissue mimics & advanced grafts, technologies that can integrate grafts, and the host vasculature have been gaining traction in recent years. In addition, using immune modulation and cell injection strategies to enhance the host’s intrinsic regenerative capacity is also set to gain traction.

On the other hand, cell sheet technology is a relatively newer concept dependent on retrieving confluent cell sheets from a substrate that responds to temperature. This enables the deposition of signaling molecules, Extracellular Matrix (ECM) molecules, and cell adhesion molecules by the cells, further assisting them to remain intact. The adoption of successive layers of these sheets to develop constructs of higher thickness is presently being witnessed and is explored in corneal reconstruction.

Emerging Applications of Gene Therapy in Regenerative Medicine

Gene therapy has high potential in treating diabetes and cancer with the help of restoring gene function. In the present scenario, gene-based therapies are used in treating patients suffering from cancer, monogenic diseases, cardiovascular disorders, infectious diseases, genetic disorders, ophthalmological indications, and central nervous system diseases.

The use of gene therapy to treat blood cancer has shown positive results in a study that included around 35 individuals. According to the American Cancer Society, gene-based drugs help in treating over 70% to 80% of blood cancer patients. The treatment is CAR-T therapy and has been tried on patients with lymphoma and leukemia. Gene-based therapy is one of the most efficient therapies as it provides treatment at genetic levels. Restoring the genetic alterations can help regain the lost functionality in cells, which provides opportunities to develop regenerative therapies.

Several healthcare entities are now investing in the R&D of gene-based therapies to meet the increasing demand for regenerative medicines. For instance, in March 2023, Pharmaron Beijing Co., Limited invested USD 190.26 million into the UK gene therapy CDMO with support from the British government. This investment was aimed at boosting the enhancement of gene therapy development across the UK. The advancements in gene therapy are higher in oncology due to the high disease burden and genetically driven cancer pathophysiology.

The steady commercial success of gene therapies is projected to accelerate the regenerative medicine market growth in the coming years. Furthermore, researchers are required to address certain technical challenges to make gene therapy practical. Researchers have begun using RNA Interference (RNAi) for developing gene therapy against chronic infectious diseases, such as Human Immunodeficiency Viruses (HIV). This is expected to support the future development of gene therapies.

How are Industries in Probiotics Market Leaping Ahead?

 Oasis of Opportunities in Probiotics

Cultural and economic shifts are shaping the probiotics market, fostering dietary supplement and food and beverage industries. Consumer trends allude to the rising prominence of probiotics, which offer a slew of health upsides, including digestive and immune health and advancements in weight management. Brands are zeroing in on additional probiotic health benefits to keep up with the soaring consumer demand. A few studies have claimed that certain strains of probiotic bacteria might prevent the common cold and influenza and/or reduce the duration of the disease. The strong link of probiotics with gut health and immunity has steered a wave of trends in digestive health.

Notably, products with probiotics claims, such as frozen yogurt, fermented drinks, cereals, snack bars, infant formula and dairy-based ice creams, have gained ground. In January 2024, the International Food Information Council (IFIC) inferred that a Consumer Insights on Gut Health and Probiotics Survey—conducted by IFIC—found that one in four Americans (those who try to consume probiotics) stated they commonly seek them in wellness drinks.

Surging demand for microbiome-nurturing ingredients has prompted manufacturers and other leaders to emphasize women’s health and cognitive health. Prevailing trends indicate the global probiotics market could reach USD 220.14 billion in revenue in 2030. The growth trajectory is a major indicator for stakeholders as to where the industry is heading.

What are the strategies that can help incumbents and startups leap the competition and keep abreast of the trends?

Bacteria-Based Ingredient Braces for Microbiome Trend

The gut microbiome has become the trailblazer as it is highly attributed to weight management and skin and cognitive health. A healthy gut microbiome has the innate ability to minimize inflammation and bolster immunity, encouraging food and beverage, pharmaceutical and cosmetic industries to explore opportunities. To illustrate, in April 2023, the U.S. FDA approved the first oral microbiome to be used as a therapeutic. The agency gave the nod to Seres Therapeutics’ live microbiome capsule Vowst; the product will reportedly be co-commercialized by Nestle.

As problems with the gut microbiome have been associated with a host of diseases, such as cancer, diabetes and obesity, researchers are expected to focus on next-generation probiotics (NGPs). Studies suggest NGPs—regulating the gut microbiome—can modulate inflammatory pathways, minimize oxidative stress and prevent neurodegenerative and viral diseases.

Opportunities and Challenges Redefine Dietary Supplements

Millennials and the Gen Z population are pinning hope on food supplements, specialty supplements, nutritional supplements and infant formula products. Probiotic supplements have gained ground to boost digestive and immune health. Pervasive obesity, high blood pressure and a sedentary lifestyle have put the spotlight on dietary supplements. In essence, probiotic strains— spore-forming probiotic bacteria—have become sought-after due to their stability. Lately, Americans are counting on probiotic dietary supplements; so much so that customized products are gradually gaining traction.

Convenient dietary products, such as capsules and chewable gummies, have become prevalent, suggesting the prospect of dietary supplements. However, in October 2023, the U.S. FDA raised an alarm bell regarding the sale of probiotic products for use in hospitalized preterm infants. The organization inferred that the product was an adulterated dietary supplement (under the Federal Food, Drug, and Cosmetic Act) as B. infantis (Bb-02) and S. thermophilus (TH-4) failed to meet the applicable safety requirements.

Future Outlook: an Emphasis on Mental Health

Soaring commercialization of probiotics alludes to the trend for functional foods and chewable tablets. Products containing natural probiotics, including naturally fermented yogurts and kimchi, are likely to gain prominence. Besides, Probiotics-enriched chocolates, snack bars, kombucha, Tempeh, Natto, Miso, Sauerkraut and kefir could be sought by millennials and Gen Z customers.

Probiotics could also boost mental health; researchers are investigating the potential of psychobiotics as a cure-all for mental health problems. A 2022 randomized controlled trial in Translational Psychiatry found that a high-dose probiotic with eight different bacteria strains helped reduce depression symptoms. Psychobiotics can also minimize the risk of Alzheimer’s disease and heart disease. The next half-decade could provide revenue-generating opportunities for probiotics manufacturers and suppliers.

How Clinical Trials Help Diagnose the Future of Medicine?

 The growing prevalence of chronic diseases and the incidence of novel diseases is expected to boost the clinical trials market. According to the World Heart Report 2023, over half a billion people worldwide are affected by Cardiovascular Diseases (CVDs), which caused over 20.5 million deaths in 2021. Furthermore, according to the Parkinson’s Foundation, approximately 1 million individuals in the U.S. currently suffer from Parkinson's Disease (PD), which is projected to increase to over 1.2 million by 2030.

The prevalence of rare or orphan diseases has garnered attention in recent years, necessitating specialized clinical trials. As diseases become more varied and complex, there is a heightened demand for specialized expertise in clinical trial design, patient recruitment, and data analysis. Trial sponsors seek experts capable of navigating the intricacies of diverse diseases. Thus, the aforementioned factors are expected to drive the market demand.

From Firsts to Finals: The Four Phases

• Phase I: Phase I clinical trials are the first stage of human testing for a new medical intervention. They focus on evaluating its safety, determining the appropriate dosage, and collecting initial data on how the body interacts with the intervention.
• Phase II: Phase II clinical trial is a controlled study conducted on a relatively larger group of patients to assess the safety and efficacy of a new medical intervention, such as a drug or treatment.
• Phase III: A Phase III clinical trial involves a large-scale and rigorously controlled study conducted to confirm and further evaluate the safety and effectiveness of a medical intervention identified in Phase II.
• Phase IV: A Phase IV clinical trial, also known as post-marketing surveillance, occurs after a medical product has received regulatory approval.

Top Trends Streamlining Clinical Trials:

• Rising Demand for Personalized Medicine: Numerous companies are focusing on the development of targeted therapies to cater to specific genetic diseases. Clinical trials are pivotal in validating these therapies, potentially leading to smaller, more specialized markets. Furthermore, several regulatory authorities offer flexibility in trial designs, with real-world evidence and favorable regulatory pathways for smaller patient populations, positively influencing market growth.
• Technological Advancements: The growing adoption of decentralized clinical trials and telemedicine in clinical trials offers several advantages, which are expected to drive the overall potential of the industry. Moreover, the integration of remote monitoring technology enables continuous patient data collection outside clinical settings. This real-time data improves trial accuracy, enhances patient engagement, and allows more comprehensive insights into patient health.
• Research & Development Activities: Collaborations between biopharmaceutical companies and CROs are expected to impact the industry positively. Contract research organizations have seen a major boost owing to rising R&D expenditures and pharmaceutical companies’ increasing focus on cost containment. Several biopharmaceutical and medical device companies are outsourcing their clinical trials to CROs to reduce product development time and cost.

The Final Diagnosis:

Clinical trials might seem like an intricate world of complex processes but they are the bridge between ground-breaking discoveries and life-saving treatments. By participating in such trials, individuals can contribute to medical progress, thereby paving the way for a healthier future. Even the smallest contribution can help make a world of great difference!

From Lab to Life: Analysing Top 5 Trends in Clinical Diagnostics

 The clinical diagnostics market, like many other businesses, is entering the Industry 4.0 revolution. The advent of digitalization, automation, and robotization has helped develop highly flexible smart laboratories. These labs can manage both high-volume/routine analyses and highly customized analyses at reasonable prices. Clinical laboratories are required to have exceptional flexibility to adapt quickly to persistent shifts and unpredictable new environments.

Mentioned below are the 5 key trends that are helping the clinical diagnostics industry survive in a dynamic environment:

1. Integration of Automation Technologies in Genomics

Over the years, the accuracy of genome sequencing has radically improved. Furthermore, sequencing and library preparation platforms are now more affordable than ever before, both of which are making the technology more extensively accessible. Advancements in data analytics have also enhanced the study of genomics by revealing unknown correlations, hidden patterns, and other insights, specifically when investigating large-scale data sets.

At the core of this advancement are automation technologies that facilitate much higher flexibility, throughputs, and low-cost solutions. Furthermore, reduced costs of DNA sequencing and genotyping have made DNA testing widely available to end-users. This has resulted in a robust growth rate in the number of consumers embracing genetic testing. An enormous number of consumers consent to making their samples available for research. Conclusively, the overall volume of generated biological data is exponentially growing.

2. Rise of Patient-centric Approaches

The changing consumer expectations have necessitated the adoption of patient-centric approaches in healthcare settings. The recent years have seen a developing interest in personalized training and diet programs as well as customized cosmetic products and procedures. While medicine has revolved around standardized procedures based on a statistically average non-existent person, automation of clinical diagnostics has implied that medical treatment can be tailor-made as per an individual’s genetic considerations.

3. Emerging At-home Diagnostics Point-of-care Testing Solutions

Advancements in clinical diagnostics technology have enabled rapid testing in patients’ homes. This helps facilitate enhanced disease monitoring, diagnosis, and management. A key advantage of digitalization in at-home and point-of-care diagnostics is the convenience of the testing procedure and the storage and analysis of results in a protected digital environment that healthcare providers can access.

4. AI-driven Medical Imaging

One of the primary benefits of AI in medical imaging is its ability to improve the efficiency and accuracy of disease diagnosis. Artificial intelligence solutions enable healthcare professionals to determine diseases with the help of optimized medical images. Healthcare professionals can precisely identify specific structures, detect abnormalities, and predict disease outcomes for enhanced clinical diagnostics.

5. Real-time diagnostics

Wearable biosensors, including watches, glasses, contact lenses, clothing, bandages, rings, and ingestible and implantable devices, collect physical health information in the form of blood pressure, heart rate, respiratory rate, skin temperature, and body motion. Compared to conventional diagnostic tests that only capture a particular parameter, real-time diagnostics deliver more robust and wide-ranging data analysis for clinical decision-making. They facilitate continuous monitoring, which provides instant feedback on irregularities and can be used to track a patient’s overall health and well-being.

What to Expect?

These trends bring new thrilling possibilities for the clinical diagnostics industry; however, they also present new challenges. These challenges include concerns regarding safety issues, patient integrity and risks associated with an ever-changing environment. With the fourth industrial revolution, relentless transformation is becoming the new normal. To tap into new business opportunities, clinical laboratories need to modify their operations and processes on a continual basis. There is no gold standard solution to address these challenges. Instead, those who are able to adapt to a dynamic environment will be the winners of the game.

Biopharmaceuticals Contract Manufacturing Market is Anticipated to Register 5.2% CAGR through 2030

 

Biopharmaceuticals Contract Manufacturing Market Growth & Trends

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 27.3 billion by 2030, growing at a CAGR of 5.2% from 2022 to 2030, according to a new report by Grand View Research, Inc. Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the companies' demands with respect to regulatory standards and new services. The pandemic has, however, also had some negative knock-on effects as budgets and resources are diverted to “COVID products” at the expense of other biologics projects in development for other therapeutic areas.

The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise during the forecast period as a consequence of changes adopted by the CMOs. This is evident through growing investment in collaborations of companies with CMOs as well as continuous efforts taken up for expanding the service portfolio. The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst. Also, biopharmaceutical contract manufacturers are observing increased demand related to COVID-19 vaccine and therapeutics. Thus, the future holds numerous opportunities for the market. For instance, in 2020, AstraZeneca and Oxford Biomedica signed a one-year clinical and commercial supply agreement for the manufacturing of AstraZeneca’s COVID-19 vaccine candidate, AZD1222.

The future growth of the market is highly dependent on the promising opportunities offered by the biopharmaceutical industry, bioprocessing industry, and contract service industry. Expansion of fill-and-finish services and increasing robustness of venture capital investments for the life science sector are two important opportunities that are anticipated to drive the market. For instance, in 2019, Shanghai HaiHe Biopharma Co. Ltd. raised USD 146.6 million as venture capital for its large cancer drug portfolio, which it shall utilize along with its outsourcing partner Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 

Request a free sample copy or view the report summary: Biopharmaceuticals Contract Manufacturing Market Report

Biopharmaceuticals Contract Manufacturing Market Report Highlights

• Mammalian-based biopharmaceutical contract manufacturing captured the largest market share about 58% in 2021 owing to the high penetration of mammalian expression systems for biologics development
• Out of all the services offered in this market, process development contributed to the largest share of 33% in 2021, owing to high capital investment, especially in downstream process
• Biologics contract manufacturing dominated its counterpart segment owing to higher demand for biologics production. However, the biosimilar segment is growing with a lucrative CAGR of 8.3% due to cost-saving advantages associated with biosimilars development
• The presence of an effective regulatory framework for biologics development in the U.S. has resulted in a large share of the North America market of 34.0% in 2021
• However, Asia Pacific is expected to emerge as the fastest-growing regional market with a CAGR of 5.8% from 2022 to 2030, owing to developing economies such as India and China incorporating developments to sustain the competition

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceuticals-contract-manufacturing-market

Biopharmaceuticals Contract Manufacturing Market Segmentation

Grand View Research has segmented the global biopharmaceuticals contract manufacturing market based on source, service, product, therapeutic area and region: 

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2017 - 2030)

• Mammalian
• Non-mammalian

Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2017 - 2030)

• Process Development
  • Downstream
  • Upstream
• Fill & Finish Operations
• Analytical & QC studies
• Packaging

Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2017 - 2030)

• Biologics
  • Monoclonal antibodies (MABs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi, & Molecular Therapy
  • Others
• Biosimilars

Biopharmaceuticals Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2017 - 2030)

• Oncology
• Autoimmune Diseases
• Metabolic Diseases
• Cardiovascular Diseases
• Neurology
• Infectious Diseases
• Others

Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK 
  • Germany
  • France
  • Italy

Spain

• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Colombia
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

UAE

List of Key Players in Biopharmaceuticals Contract Manufacturing Market

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologie GmbH
• JRS PHARMA
• AGC Biologics
• ProBioGen
• FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
• Toyobo Co. Ltd.
• Samsung BioLogics
• Thermo Fisher Scientific, Inc.
• Binex Co., Ltd.
• WuXi Biologics
• AbbVie, Inc.
• Novartis AG
• ADMA Biologics, Inc.
• Catalent, Inc
• Cambrex Corporation
• Pfizer Inc.
• Siegfried Holding AG

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global 5G Chipset Market to Register Stable Expansion During 2023 – 2030: Grand View Research Inc.

 5G Chipset Market Growth & Trends

The global 5G chipset market size is estimated to reach USD 143.69 billion by 2030, exhibiting a CAGR of 20.3% from 2023 to 2030, according to a new study by Grand View Research, Inc. With the increasing demand for 5G-enabled devices, there is a growing need for more powerful and efficient 5G chipsets that can support these devices. To improve performance and efficiency, many chipsets are being designed with built-in Artificial Intelligence (AI) capabilities, which allow devices to process data more quickly and accurately and make more intelligent decisions.

Additionally, there is an increasing focus on the development of specialized 5G chipsets for specific use cases, such as IoT devices, automotive applications, and virtual and augmented reality applications, which bodes well for the growth of the market over the coming years. The rising demand for high-speed internet is a major driving force behind the growth of the market. With the increasing popularity of bandwidth-intensive applications such as high-quality video streaming, virtual and augmented reality, and cloud gaming, there is a need for faster and more reliable internet connectivity.

The 5G network is designed to provide significantly faster download and upload speeds, lower latency, and greater capacity than previous generations of wireless networks. As a result, there is a growing need for 5G chipsets that can enable high-speed internet connectivity for a wide range of devices, including smartphones, laptops, IoT devices, and more.

With the rollout of 5G networks in many parts of the world, consumers are increasingly looking for devices that can take advantage of the new technology. 5G smartphones offer faster download and upload speeds, lower latency, and greater capacity than previous generations of smartphones, allowing users to enjoy faster and more reliable internet connectivity. As a result, there is a growing need for 5G chipsets that can power these devices, enabling them to provide the high-speed connectivity that users demand.

The COVID-19 pandemic increased the demand for remote work and online education, which in turn led to a surge in demand for devices that can provide fast and reliable internet connectivity. This created an opportunity for the market, as 5G technology is designed to provide faster and more reliable connectivity than previous generations of wireless networks. As a result, there was a significant increase in demand for 5G-enabled devices, including smartphones, laptops, and IoT devices.

Request a free sample copy or view report summary: 5G Chipset Market Report

5G Chipset Market Report Highlights

• The RFICs segment dominated the market in 2022. The rising complexity of smartphones, which necessitates the use of additional RF transceiver ICs to support numerous antennas for features such as 4G/5G connection, Wi-Fi, Bluetooth, GPS, and NFC, is a major factor driving the segment growth
• The Sub-6 GHz segment dominated the market in 2022. Increasing use of Sub-6 GHz technologies to provide comprehensive coverage in urban and rural regions, since these frequency bands offer more range and penetration than higher mmWave bands, is a primary factor driving the segment growth
• The 7 nm segment dominated the market in 2022. The increasing use of the 7 nm technology node in chip design, which offers lower power consumption, greater switching performance, and higher density, is a primary factor driving the segment growth
• The smartphones segment dominated the market in 2022. The segment's growth is mostly attributed to rising customer demand for mobile connection that is both quicker and more dependable
• The IT & Telecommunication segment dominated the market in 2022. Significant factors influencing the segment growth include major manufacturers' extensive efforts in developing 5G chipset modules for telecom base stations, and other communication equipment’s
• The Asia Pacific region dominated the market in 2022 owing to This is rising demand in in high-speed connection by consumers and the growing usage of modern technologies such as IoT, AI, and cloud computing 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-5g-chipset-market

5G Chipset Market Segmentation

Grand View Research has segmented the global 5G chipset market based on type, operating frequency, processing node type, deployment type, vertical, and region:

5G Chipset Type Outlook (Revenue, USD Million, 2019 - 2030)

• Modems
• RFICs
  • RF Transceivers
  • RF FE
• Others

5G Chipset Operating Frequency Outlook (Revenue, USD Million, 2019 - 2030)

• Sub-6 GHz
• 24-39 Ghz
• Above 39 Ghz

5G Chipset Processing Node Type Outlook (Revenue, USD Million, 2019 - 2030)

• 7 nm
• 10 nm
• Others

5G Chipset Deployment Type Outlook (Revenue, USD Million, 2019 - 2030)

• Telecom Base Station Equipment
• Smartphones/Tablets
  • Single-mode
    • Standalone
    • Non-standalone
  • Multi-mode
• Connected Vehicles
  • Single-mode
    • Standalone
    • Non-standalone
  • Multi-mode
• Connected Devices
  • Single-mode
    • Standalone
    • Non-standalone
  • Multi-mode
• Broadband Access Gateway Devices
  • Single-mode
    • Standalone
    • Non-standalone
  • Multi-mode
• Others
  • Single-mode
    • Standalone
    • Non-standalone
  • Multi-mode

5G Chipset Vertical Outlook (Revenue, USD Million, 2019 - 2030)

• Manufacturing
• Energy & Utilities
• Media & Entertainment
• IT & Telecom
• Transportation & Logistics
• Healthcare
• Others

5G Chipset Regional Outlook (Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • Sweden
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• MEA (Middle East & Africa)
  • Kingdom of Saudi Arabia (KSA)
  • UAE
  • South Africa

List of Key Players in the 5G Chipset Market

• Huawei Technologies, Inc
• MediaTek Inc
• Intel Corporation
• Samsung
• Infineon Technologies AG
• Qualcomm Technologies, Inc
• Unisoc Communications Inc.
• Qorvo, Inc.
• Anokiwave, Inc
• Xilinx

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Potash Market To Hold a High Potential for Growth by 2032: Grand View Research Inc.

 Potash Market Growth & Trends

The global potash market size is expected to reach USD 93.50 billion by 2032, growing at a CAGR of 4.9% from 2023 to 2032, according to a new study by Grand View Research, Inc. This is attributed to the increasing demand for food and efficient usage of agricultural land. As consumers seek healthier options, there has been a surge in demand for high-value crops like fruits, vegetables, and specialty crops, boosting the demand for potash. Furthermore, the adoption of precision agriculture techniques has become increasingly prevalent in recent years. Precision agriculture involves using advanced technologies and data-driven approaches, such as soil testing and targeted nutrient management, to make informed decisions about fertilizer application.

Farmers are embracing precise and site-specific methods for applying fertilizers, based on field variability and crop requirements. This trend makes way for optimized resource utilization, improved crop performance, and enhanced overall efficiency in agricultural practices. Consequently, adopting precision agriculture methods has contributed to the rising product demand as farmers strive to maximize crop yields and optimize nutrient management. Changing dietary preferences, growing consumer awareness, and adoption of precision agriculture techniques have significantly impacted the market growth. The increased demand for high-value crops and the emphasis on optimizing crop productivity and quality have fueled the product demand as an essential nutrient.

These trends underscore the product’s importance in supporting sustainable and efficient agricultural practices while meeting the evolving needs of modern consumers. However, price volatility remains a significant factor influenced by production capacities, global demand fluctuations, and currency exchange rates. In addition, supply chain constraints, including transportation and logistics challenges, can impact the product availability and pricing. These factors present obstacles to market growth and present challenges to industry players while meeting the evolving demands. Asia Pacific will emerge as the fastest-growing region at a CAGR of 5.7% from 2023 to 2032 due to high population, land fertility, increased demand for food grains, and effective use of land through fertilizer.

Request a free sample copy or view report summary: Potash Market Report

Potash Market Report Highlights

• Potassium chloride is estimated to emerge as the fastest-growing application segment with a CAGR of 5.2% from 2023 to 2032
• The demand for this commodity has grown substantially in recent years due to the significant increase in agricultural activities
• The agriculture segment is estimated to register the fastest CAGR of 5.1% from 2023 to 2032
• Key players in the industry are involved in broadening their product portfolio and global presence.
• In September 2020, the German potash and salt mining company, K+S, agreed to sell its America’s salt business to Stone Canyon Industries Holdings for approximately $3.2 billion
• Nutrien Ltd., one of the world's largest potash producers, announced in April 2021 that it has acquired Israeli specialty plant nutrient supplier, Agri body Technologies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-potash-market

Potash Market Segmentation

Grand View Research has segmented the global potash market based on product, end-use, and region:

Potash Product Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2032)

• Potassium Chloride
• Potassium Sulphate
• Potassium Nitrate
• Other Products

Potash End-use Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2032)

• Agriculture
• Non-Agriculture

Potash Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2032)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Spain
  • Italy
  • The Netherlands
  • Germany
  • France
  • UK
  • Belarus
  • Belgium
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Vietnam
  • Malaysia
  • Thailand
  • Australia
• Central & South America
  • Brazil
  • Argentina
  • Chile
• Middle East & Africa
  • Morocco
  • Jordan
  • Saudi Arabia
  • South Africa
  • Israel

List of Key Players in Potash Market

• JSC Belaruskali
• Compass Minerals Intl. Ltd.
• Mosaic Company
• Uralkali
• Rio Tinto Ltd.
• BHP Billiton Ltd.
• Eurochem
• Red Metal Ltd.
• Encanto Potash Corp. (EPC)
• Intrepid Potash Inc.
• K+S Aktiengesellschaft
• Nutrien Ltd.

Explore Horizon, the world's most expansive market research database

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.